As of 2025-07-03, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -1.72 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.85 CAD, the upside of Medicenna Therapeutics Corp is -302.27%.
Based on its market price of 0.85 CAD and our intrinsic valuation, Medicenna Therapeutics Corp (MDNA.TO) is overvalued by 302.27%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.72 - -1.72 | -1.72 | -302.27% |
| P/E | (0.15) - (0.23) | (0.19) | -122.2% |
| DDM - Stable | (1.67) - (6.76) | (4.22) | -595.9% |
| DDM - Multi | (0.89) - (3.00) | (1.39) | -263.9% |
| Market Cap (mil) | 66.49 |
| Beta | 1.33 |
| Outstanding shares (mil) | 78.22 |
| Enterprise Value (mil) | 36.67 |
| Market risk premium | 5.10% |
| Cost of Equity | 13.49% |
| Cost of Debt | 5.00% |
| WACC | 8.59% |